MCID: INF029
MIFTS: 10

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Categories: Cancer diseases, Nephrological diseases

Aliases & Classifications for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

MalaCards integrated aliases for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant:

Name: Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant 12 17 71
Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant Without Heterologous Elements 12
Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements 12

Classifications:



External Ids:

Disease Ontology 12 DOID:7553
NCIt 49 C39824
UMLS 71 C1512743

Summaries for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

MalaCards based summary : Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, is also known as infiltrating bladder urothelial carcinoma, sarcomatoid variant without heterologous elements, and has symptoms including dysuria The drugs leucovorin and Pemetrexed have been mentioned in the context of this disorder.

Related Diseases for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Symptoms & Phenotypes for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

UMLS symptoms related to Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant:


dysuria

Drugs & Therapeutics for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Drugs for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
leucovorin Approved Phase 2 58-05-9 6006 143
2
Pemetrexed Approved, Investigational Phase 2 150399-23-8, 137281-23-3 446556 60843
3
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
4 Folic Acid Antagonists Phase 2
5 Antibodies, Monoclonal Phase 2
6 Vitamin B Complex Phase 2
7 Vitamin B9 Phase 2
8 Folate Phase 2
9 Immunologic Factors Phase 2
10 Immunoglobulins Phase 2
11 Antibodies Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Phase II Trial to Evaluate Combination Therapy With Pemetrexed and Avelumab in Previously Treated Patients With MTAP-Deficient Advanced Urothelial Cancer Recruiting NCT03744793 Phase 2 Avelumab;Pemetrexed

Search NIH Clinical Center for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Genetic Tests for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Anatomical Context for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Publications for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Variations for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Expression for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Search GEO for disease gene expression data for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant.

Pathways for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

GO Terms for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

Sources for Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....